An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells
Open Access
- 12 May 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (24) , 20513-20524
Abstract
An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cellsKeywords
This publication has 34 references indexed in Scilit:
- MDR-1, Bcl-xL, H. pylori, and Wnt/β-catenin signalling in the adult stomach: how much is too much?Laboratory Investigation, 2012
- Inhibitor of Nrf2 (INrf2 or Keap1) Protein Degrades Bcl-xL via Phosphoglycerate Mutase 5 and Controls Cellular ApoptosisJournal of Biological Chemistry, 2011
- Many CeramidesJournal of Biological Chemistry, 2011
- Sphingolipids and expression regulation of genes in cancerProgress in Lipid Research, 2011
- Apoptotic Sphingolipid Ceramide in Cancer TherapyJournal of Lipids, 2011
- Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and β-catenin signalingMolecular Cancer, 2010
- Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motilityFEBS Letters, 2009
- A New Mixed-Backbone Oligonucleotide against Glucosylceramide Synthase Sensitizes Multidrug-Resistant Tumors to ApoptosisPLOS ONE, 2009
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.Journal of Clinical Investigation, 1997